150 related articles for article (PubMed ID: 7919151)
1. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
Ricardo SD; Bertram JF; Ryan GB
J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
[TBL] [Abstract][Full Text] [Related]
2. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
Ricardo SD; Bertram JF; Ryan GB
Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species in puromycin aminonucleoside nephrosis: in vitro studies.
Ricardo SD; Bertram JF; Ryan GB
Kidney Int; 1994 Apr; 45(4):1057-69. PubMed ID: 8007575
[TBL] [Abstract][Full Text] [Related]
4. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
Kojima K; Matsui K; Nagase M
Am J Kidney Dis; 2000 Jun; 35(6):1175-85. PubMed ID: 10845833
[TBL] [Abstract][Full Text] [Related]
5. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
Higuchi A
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
Magil A
J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy.
Gwinner W; Landmesser U; Brandes RP; Kubat B; Plasger J; Eberhard O; Koch KM; Olbricht CJ
J Am Soc Nephrol; 1997 Nov; 8(11):1722-31. PubMed ID: 9355075
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
Olson JL; Rennke HG; Venkatachalam MA
Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
[TBL] [Abstract][Full Text] [Related]
9. A role for oxygen free radicals in aminonucleoside nephrosis.
Diamond JR; Bonventre JV; Karnovsky MJ
Kidney Int; 1986 Feb; 29(2):478-83. PubMed ID: 3702206
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
[TBL] [Abstract][Full Text] [Related]
11. Effects of saikosaponin-d on aminonucleoside nephrosis in rats.
Abe H; Orita M; Konishi H; Arichi S; Odashima S
Eur J Pharmacol; 1986 Jan; 120(2):171-8. PubMed ID: 3948917
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
Yamanaka M; Tamura Y; Kuribayashi-Okuma E; Uchida S; Shibata S
Am J Physiol Renal Physiol; 2023 Feb; 324(2):F168-F178. PubMed ID: 36454699
[TBL] [Abstract][Full Text] [Related]
13. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
Inokuchi S; Shirato I; Kobayashi N; Koide H; Tomino Y; Sakai T
Kidney Int; 1996 Oct; 50(4):1278-87. PubMed ID: 8887289
[TBL] [Abstract][Full Text] [Related]
14. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
[TBL] [Abstract][Full Text] [Related]
15. Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats.
Pinto JA; Brewer DB
J Pathol; 1975 Jul; 116(3):149-64. PubMed ID: 1104792
[TBL] [Abstract][Full Text] [Related]
16. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of puromycin aminonucleoside on the ultrastructure of rat glomerular podocytes.
Bertram JF; Messina A; Ryan GB
Cell Tissue Res; 1990 May; 260(3):555-63. PubMed ID: 2372813
[TBL] [Abstract][Full Text] [Related]
18. A morphometric, biochemical and histochemical comparison of puromycin aminonucleoside and hyperalbuminaemic induced proteinurias in the female Wistar rat.
Lawrence GM; Brewer DB
J Pathol; 1983 Feb; 139(2):115-40. PubMed ID: 6827398
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries.
Kawamura T; Yoshioka T; Bills T; Fogo A; Ichikawa I
Kidney Int; 1991 Aug; 40(2):291-301. PubMed ID: 1942778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
